{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:44:09Z","timestamp":1790113449751,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["20SG43"],"award-info":[{"award-number":["20SG43"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M712155"],"award-info":[{"award-number":["2022M712155"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","award":["21YF1422700"],"award-info":[{"award-number":["21YF1422700"]}],"id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1459000"],"award-info":[{"award-number":["22ZR1459000"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1460800"],"award-info":[{"award-number":["21ZR1460800"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374002"],"award-info":[{"award-number":["82374002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304882"],"award-info":[{"award-number":["82304882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157421","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:38:54Z","timestamp":1761089934000},"page":"157421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Membrane cholesterol-dependent dual VEGFR2\/FGFR1 inhibition by ginsenoside Rg3 to overcome gefitinib resistance in NSCLC"],"prefix":"10.1016","volume":"148","author":[{"given":"Min","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-8613","authenticated-orcid":false,"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-1221","authenticated-orcid":false,"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157421_bib0001","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2174\/0113816128306300240522074056","article-title":"The effect of Ginseng supplementation on Lipid profile: gRADE-assessed systematic review and dose-response meta-analysis of randomized Controlled trials","volume":"30","author":"Arabi","year":"2024","journal-title":"Curr. Pharm. Design."},{"key":"10.1016\/j.phymed.2025.157421_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1653750","article-title":"The effect of Shenyi capsule on non-small-cell lung cancer combined with chemotherapy from the Yin-Yang perspective","author":"Cai","year":"2021","journal-title":"Evid.-Based. Compl. Alt"},{"key":"10.1016\/j.phymed.2025.157421_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176871","article-title":"Strategies for enhancing non-small cell lung cancer treatment: integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy","volume":"980","author":"Chen","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157421_bib0004","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/s41591-023-02554-7","article-title":"Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial","volume":"29","author":"Cho","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.157421_bib0005","author":"Clark","year":"2024","journal-title":"Non-Small Cell Lung Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0006","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157421_bib0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2015.01.039","article-title":"EGFR T790M resistance mutation in non small-cell lung carcinoma","volume":"444","author":"Denis","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phymed.2025.157421_bib0008","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.2024.10613","article-title":"Ivonescimab plus chemotherapy in non-small cell lung cancer with EGFR variant: a randomized clinical trial","volume":"332","author":"Fang","year":"2024","journal-title":"Jama-J. Am. Med. Assoc."},{"key":"10.1016\/j.phymed.2025.157421_bib0009","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejps.2008.04.005","article-title":"P-glycoprotein inhibition by membrane cholesterol modulation","volume":"34","author":"Fenyvesi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2025.157421_bib0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.stem.2023.05.006","article-title":"We need to talk about lung cancer's cholesterol-hoarding problem","volume":"30","author":"Fessler","year":"2023","journal-title":"Cell. Stem. Cell."},{"key":"10.1016\/j.phymed.2025.157421_bib0011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-0716-0814-2_9","article-title":"Lipid raft isolation by sucrose gradient centrifugation and visualization of raft-located proteins by fluorescence microscopy: the use of combined techniques to assess Fas\/CD95 location in rafts during apoptosis triggering","volume":"2187","author":"Gajate","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phymed.2025.157421_bib0012","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.phymed.2025.157421_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2024.184366","article-title":"Mode of molecular interaction of triterpenoid saponin ginsenoside Rh2 with membrane lipids in liquid-disordered phases","volume":"1866","author":"Garza-Miyazato","year":"2024","journal-title":"Bba-Biomembranes"},{"key":"10.1016\/j.phymed.2025.157421_bib0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lungcan.2010.12.008","article-title":"Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence","volume":"71","author":"Gridelli","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0015","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/iub.2823","article-title":"Cholesteryl ester transfer protein knock-down in conjunction with a cholesterol-depleting agent decreases tamoxifen resistance in breast cancer cells","volume":"76","author":"Gu","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phymed.2025.157421_bib0016","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2018.09.028","article-title":"Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity","volume":"439","author":"Gupta","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157421_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phymed.2025.157421_bib0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1535-7163.MCT-16-0105","article-title":"Strategies to overcome bypass mechanisms mediating clinical resistance to EGFR tyrosine kinase inhibition in lung cancer","volume":"16","author":"Husain","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2025.157421_bib0019","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/5584_2022_759","article-title":"Rafting on the plasma membrane: lipid rafts in signaling and disease","volume":"1436","author":"Isik","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phymed.2025.157421_bib0020","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12272-001-1137-y","article-title":"Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation","volume":"31","author":"Kwon","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ki.1994.17","article-title":"A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat","volume":"45","author":"Laurens","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2025.157421_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13009","article-title":"Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment","volume":"54","author":"Liu","year":"2021","journal-title":"Cell. Proliferat."},{"key":"10.1016\/j.phymed.2025.157421_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0025","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/cddis.2011.28","article-title":"Cell-type-specific regulation of raft-associated Akt signaling","volume":"2","author":"Liu","year":"2011","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2025.157421_bib0026","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1055\/s-0042-114780","article-title":"alpha-hederin induces apoptosis, membrane permeabilization and morphologic changes in two cancer cell lines through a cholesterol-dependent mechanism","volume":"82","author":"Lorent","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2025.157421_bib0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11655-007-9002-6","article-title":"Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer","volume":"14","author":"Lu","year":"2008","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2025.157421_bib0028","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.abb.2004.03.020","article-title":"Lipid rafts-protein association and the regulation of protein activity","volume":"426","author":"Lucero","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phymed.2025.157421_bib0029","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10120-021-01210-8","article-title":"Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains","volume":"24","author":"Lv","year":"2021","journal-title":"Gastric. Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0030","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.bbamem.2017.09.019","article-title":"Sterol-recognition ability and membrane-disrupting activity of ornithogalum saponin OSW-1 and usual 3-O-glycosyl saponins","volume":"1859","author":"Malabed","year":"2017","journal-title":"Bba-Biomembranes"},{"key":"10.1016\/j.phymed.2025.157421_bib0031","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/0008-5472.CAN-24-0769","article-title":"Dual inhibition of SYK and EGFR overcomes chemoresistance by inhibiting CDC6 and blocking DNA replication","volume":"84","author":"Mandal","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0032","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12935-017-0457-z","article-title":"Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells","volume":"17","author":"Notarangelo","year":"2017","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.phymed.2025.157421_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lungcan.2017.07.006","article-title":"Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients","volume":"111","author":"Ou","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","article-title":"Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERRalpha re-expression","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","article-title":"Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERRalpha re-expression","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0036","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1476-5381.2010.00768.x","article-title":"Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt","volume":"160","author":"Park","year":"2010","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157421_bib0037","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function","volume":"47","author":"Pike","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0038","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function","volume":"47","author":"Pike","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0039","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.4238\/2014.May.9.2","article-title":"Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway","volume":"13","author":"Qiu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.phymed.2025.157421_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1897508","article-title":"Ginsenosides Rg1 and CK control temozolomide resistance in glioblastoma cells by modulating cholesterol efflux and lipid raft distribution","author":"Qiu","year":"2022","journal-title":"Evid-Based. Compl. Alt"},{"key":"10.1016\/j.phymed.2025.157421_bib0041","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3109\/09537104.2016.1174203","article-title":"Comparative lipidomics and proteomics analysis of platelet lipid rafts using different detergents","volume":"27","author":"Rabani","year":"2016","journal-title":"Platelets."},{"key":"10.1016\/j.phymed.2025.157421_bib0042","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Ne."},{"key":"10.1016\/j.phymed.2025.157421_bib0043","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12964-024-01876-4","article-title":"Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?","volume":"22","author":"Ruzzi","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phymed.2025.157421_bib0044","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157421_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127440","article-title":"Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: a review","volume":"253","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157421_bib0046","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2025.157421_bib0047","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1038\/s41467-022-31825-z","article-title":"Stomatin modulates adipogenesis through the ERK pathway and regulates fatty acid uptake and lipid droplet growth","volume":"13","author":"Wu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.157421_bib0048","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157421_bib0049","article-title":"Receptor tyrosine kinase fusion-mediated resistance to EGFR-TKI in EGFR-mutant NSCLC: a multi-center analysis and literature review","author":"Xia","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.phymed.2025.157421_bib0050","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.bcp.2013.02.025","article-title":"Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition","volume":"85","author":"Yun","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157421_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101112","article-title":"Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane","volume":"76","author":"Zhang","year":"2024","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phymed.2025.157421_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206878","article-title":"Targeting squalene epoxidase confers metabolic vulnerability and overcomes chemoresistance in HNSCC","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phymed.2025.157421_bib0053","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","author":"Zhou","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132501058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132501058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:30:01Z","timestamp":1773293401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094471132501058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"alternative-id":["S094471132501058X"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157421","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane cholesterol-dependent dual VEGFR2\/FGFR1 inhibition by ginsenoside Rg3 to overcome gefitinib resistance in NSCLC","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157421"}}